PMID: 7545155Sep 1, 1995Paper

Genotypic identification of two groups within the species Bacteroides fragilis by ribotyping and by analysis of PCR-generated fragment patterns and insertion sequence content

Journal of Bacteriology
I PodglajenE Collatz

Abstract

Molecular typing allowed the separation of the species Bacteroides fragilis into two genotypically distinct groups. A unique set of 50 strains of B. fragilis carrying the chromosomal metallo-beta-lactamase gene cfiA was subjected to a comparative analysis with respect to sets of up to 250 randomly collected strains devoid of this gene. The two groups were found to be distinct on the basis of the following results: (i) ribotyping, after DNA digestion with AvaI, revealed a practically homogeneous DNA fragment pattern for the cfiA-positive strains and distinct multiple patterns for the cfiA-negative strains; (ii) PCR, arbitrarily primed with an experimentally selected decamer, generated fragment patterns typical for the strains of each group; (iii) the three insertion sequences described to date in the species B. fragilis, i.e., IS4351, IS942, and IS1186, were all but confined to the cfiA-positive group, in which they were capable of providing promoter sequences for the transcription of cfiA; and (iv) the cepA gene, encoding the so-called endogenous cephalosporinase of B. fragilis, was found exclusively in the cfiA-negative group, in which it was present in ca. 70% of the strains. The cfiA-, cepA-negative fraction was not characte...Continue Reading

References

Jan 1, 1979·The Journal of Infectious Diseases·G PriviteraM Sebald
Nov 1, 1992·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M R JacobsP C Appelbaum
Jun 1, 1992·Research in Microbiology·S I Mazurier, K Wernars
Feb 1, 1992·The Journal of Antimicrobial Chemotherapy·M HedbergC E Nord
Nov 25, 1990·Nucleic Acids Research·J G WilliamsS V Tingey
Jan 1, 1991·Journal of Bacteriology·W G WeisburgD J Lane
May 15, 1991·The Biochemical Journal·R P AmblerS G Waley
Aug 1, 1990·Antimicrobial Agents and Chemotherapy·B A RasmussenF P Tally
Jun 1, 1990·The Journal of Antimicrobial Chemotherapy·N A CornickS M Finegold
Oct 1, 1985·Journal of Bacteriology·W G WeisburgC R Woese
Sep 1, 1986·Annales De L'Institut Pasteur. Microbiology·F Grimont, P A Grimont
Feb 1, 1988·The Journal of Infectious Diseases·T L StullT D Edlind
Aug 1, 1987·Journal of Bacteriology·J L RasmussenF L Macrina
May 1, 1988·Antimicrobial Agents and Chemotherapy·G J CuchuralC Pierson
Nov 1, 1986·Antimicrobial Agents and Chemotherapy·G J CuchuralF P Tally
May 16, 1980·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·R P Ambler
Jan 1, 1984·Annual Review of Microbiology·A A Salyers
Dec 1, 1983·The Journal of Antimicrobial Chemotherapy·F P Tally, N V Jacobus
Dec 1, 1983·Antimicrobial Agents and Chemotherapy·A YotsujiS Mitsuhashi
Jun 1, 1993·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·K BandohN Kato
Jun 1, 1993·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·B A RasmussenF P Tally
Jan 1, 1978·Antimicrobial Agents and Chemotherapy·J Wüst, T D Wilkins

❮ Previous
Next ❯

Citations

May 9, 2008·Current Infectious Disease Reports·John Holton
Apr 15, 2017·Critical Reviews in Microbiology·Joachim VandecraenRob Van Houdt
Jan 6, 2018·Infectious Diseases·Károly Péter SárváriEdit Urbán
Feb 2, 2006·Current Microbiology·Manfred FilleReiner Schaumann
Jan 31, 2008·Expert Opinion on Investigational Drugs·Varsha Gupta
Sep 9, 2008·The Journal of Antimicrobial Chemotherapy·Nuria GarcíaAlberto Quesada
Sep 4, 2009·The Korean journal of laboratory medicine·Kyoung Ho RohYunsop Chong
Jun 2, 2016·The Journal of Antimicrobial Chemotherapy·József SókiEdit Urbán
Apr 25, 2018·Journal of Oral Microbiology·Ingar OlsenGena D Tribble
Apr 5, 2000·The Journal of Antimicrobial Chemotherapy·W das Graças Silva E SouzaM C de Souza Ferreira
Dec 13, 2005·The Journal of Antimicrobial Chemotherapy·József SókiBrian I Duerden
Dec 3, 1999·Letters in Applied Microbiology·K E AvelarM C Ferreira
Mar 3, 2010·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Z SuH Xu
Jun 19, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David W Hecht
Aug 19, 2000·Infection and Immunity·J V CalifanoF E Dewhirst
Jun 13, 2001·Infection and Immunity·M J CoyneL E Comstock
Jan 16, 2007·Clinical Microbiology Reviews·Florence DepardieuPatrice Courvalin
Feb 27, 2003·Antimicrobial Agents and Chemotherapy·Naoki KatoEiichi Ohtsubo
Apr 16, 2005·Clinical Microbiology Reviews·Timothy R WalshPatrice Nordmann
Oct 31, 2006·Applied and Environmental Microbiology·Simy L BuckwoldAugusto A Franco
Apr 14, 2018·Acta Microbiologica Et Immunologica Hungarica·Maja BogdanJózsef Sóki
Nov 20, 2012·International Journal of Antimicrobial Agents·József SókiUNKNOWN ESCMID Study Group on Anaerobic Infections
Jul 11, 1998·Plasmid·C J SmithD P Bayley
Feb 1, 1997·Antimicrobial Agents and Chemotherapy·B A Rasmussen, K Bush
Nov 14, 1997·Journal of Clinical Microbiology·P LeszczynskiF Meisel-Mikolajczyk
Aug 1, 2002·Journal of Clinical Microbiology·Corinne ArpinClaudine Quentin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.